Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:JNJNYSE:MRK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$163.63+0.3%$158.68$140.68▼$169.99$394.32B0.477.59 million shs5.76 million shsMRKMerck & Co., Inc.$89.18+1.8%$91.92$81.04▼$134.63$225.27B0.3511.01 million shs12.39 million shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson0.00%+0.14%-0.97%+14.16%+3.44%MRKMerck & Co., Inc.0.00%-4.56%-3.31%-9.34%-32.41%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationJNJJohnson & Johnson4.3987 of 5 stars2.33.04.23.93.52.50.6MRKMerck & Co., Inc.5 of 5 stars4.35.05.03.92.23.33.8Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJNJJohnson & Johnson 2.56Moderate Buy$171.334.71% UpsideMRKMerck & Co., Inc. 2.65Moderate Buy$117.1231.33% UpsideCurrent Analyst Ratings BreakdownLatest MRK and JNJ Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/10/2025JNJJohnson & JohnsonGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral3/5/2025JNJJohnson & JohnsonBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$159.00 ➝ $171.002/19/2025JNJJohnson & JohnsonRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.002/18/2025MRKMerck & Co., Inc.Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$128.00 ➝ $105.002/12/2025MRKMerck & Co., Inc.GuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$122.00 ➝ $115.002/10/2025MRKMerck & Co., Inc.TD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$121.00 ➝ $100.002/10/2025MRKMerck & Co., Inc.TD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$121.00 ➝ $100.002/5/2025MRKMerck & Co., Inc.Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$118.00 ➝ $112.002/5/2025MRKMerck & Co., Inc.BMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$105.00 ➝ $96.002/5/2025MRKMerck & Co., Inc.CitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$125.00 ➝ $115.002/5/2025MRKMerck & Co., Inc.Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$113.00 ➝ $106.00(Data available from 3/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJNJJohnson & Johnson$88.82B4.44$13.45 per share12.17$29.69 per share5.51MRKMerck & Co., Inc.$64.17B3.51$3.09 per share28.82$14.85 per share6.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJNJJohnson & Johnson$14.07B$6.6524.6114.782.5618.20%34.24%13.63%4/15/2025 (Estimated)MRKMerck & Co., Inc.$17.12B$6.7313.259.010.7726.67%45.35%17.36%4/24/2025 (Estimated)Latest MRK and JNJ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/24/2025N/AMRKMerck & Co., Inc.$2.16N/AN/AN/A$15.59 billionN/A4/15/2025N/AJNJJohnson & Johnson$2.59N/AN/AN/A$21.65 billionN/A2/4/2025Q4 2024MRKMerck & Co., Inc.$1.85$1.72-$0.13$1.48$15.51 billion$15.62 billion1/22/2025Q4 2024JNJJohnson & Johnson$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthJNJJohnson & Johnson$4.963.03%+5.43%74.59%63 YearsMRKMerck & Co., Inc.$3.243.63%+5.73%48.14%14 YearsLatest MRK and JNJ DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date1/28/2025MRKMerck & Co., Inc.quarterly$0.813.32%3/17/20253/17/20254/7/20251/2/2025JNJJohnson & Johnsonquarterly$1.243.43%2/18/20252/18/20253/4/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJNJJohnson & Johnson0.431.110.86MRKMerck & Co., Inc.0.791.361.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJNJJohnson & Johnson69.55%MRKMerck & Co., Inc.76.07%Insider OwnershipCompanyInsider OwnershipJNJJohnson & Johnson0.16%MRKMerck & Co., Inc.0.09%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJNJJohnson & Johnson152,7002.41 billion2.40 billionOptionableMRKMerck & Co., Inc.69,0002.53 billion2.53 billionOptionableMRK and JNJ HeadlinesRecent News About These CompaniesLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRKMarch 31 at 7:25 AM | accessnewswire.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by HighPoint Advisor Group LLCMarch 31 at 7:19 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Purchased by Franklin Resources Inc.March 31 at 7:09 AM | marketbeat.comMRK SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Merck & Co., Inc. Investors Have Opportunity to Lead Class Action Lawsuit!March 31 at 7:00 AM | accessnewswire.comB. Metzler seel. Sohn & Co. AG Grows Position in Merck & Co., Inc. (NYSE:MRK)March 31 at 6:57 AM | marketbeat.comRodgers Brothers Inc. Grows Stock Holdings in Merck & Co., Inc. (NYSE:MRK)March 31 at 6:56 AM | marketbeat.comSummit Financial LLC Increases Stock Holdings in Merck & Co., Inc. (NYSE:MRK)March 31 at 6:39 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Alliancebernstein L.P.March 31 at 6:38 AM | marketbeat.comLost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact The ...March 31 at 6:32 AM | gurufocus.comSt. James Investment Company LLC Has $9.72 Million Stake in Merck & Co., Inc. (NYSE:MRK)March 31 at 6:14 AM | marketbeat.comAIA Group Ltd Buys 200,498 Shares of Merck & Co., Inc. (NYSE:MRK)March 31 at 6:00 AM | marketbeat.comWellington Management Group LLP Grows Stock Position in Merck & Co., Inc. (NYSE:MRK)March 31 at 5:52 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Holdings Reduced by Skba Capital Management LLCMarch 31 at 5:52 AM | marketbeat.comLost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact The Gross Law FirmMarch 31 at 5:45 AM | prnewswire.comCIBC Private Wealth Group LLC Lowers Stock Position in Merck & Co., Inc. (NYSE:MRK)March 31 at 5:25 AM | marketbeat.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRKMarch 30 at 12:07 PM | accessnewswire.comROSEN, NATIONAL INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRKMarch 30 at 12:00 PM | accessnewswire.comMerck & Co., Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - MRKMarch 30 at 8:47 AM | accessnewswire.comROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRKMarch 30 at 8:42 AM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines – MRKMarch 30 at 8:00 AM | globenewswire.comO Shaughnessy Asset Management LLC Has $28.07 Million Stake in Merck & Co., Inc. (NYSE:MRK)March 30 at 7:28 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWarren Buffett Swaps VOO for This Reliable Dividend StockBy Sarah Horvath | March 7, 2025View Warren Buffett Swaps VOO for This Reliable Dividend StockNVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBy Thomas Hughes | March 12, 2025View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?Archer Aviation Stock Climbs as Midnight eVTOL Nears RealityBy Jeffrey Neal Johnson | March 10, 2025View Archer Aviation Stock Climbs as Midnight eVTOL Nears RealityResilient Investing: 3 Stocks Built to Weather Market VolatilityBy Jeffrey Neal Johnson | March 17, 2025View Resilient Investing: 3 Stocks Built to Weather Market VolatilityMRK and JNJ Company DescriptionsJohnson & Johnson NYSE:JNJ$163.63 +0.50 (+0.31%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$163.36 -0.27 (-0.17%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.Merck & Co., Inc. NYSE:MRK$89.18 +1.58 (+1.80%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$89.15 -0.03 (-0.03%) As of 03/28/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 03/24 - 03/28 JPMorgan: The 'NVIDIA of Banking' Poised for More Gains? Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback Joby Aviation Stock: Analyst Confidence and Smart Money Align Ibotta Stock: Why the Buyback Looks Like a Bullish Bet Archer Aviation Stock Sees Surge in Institutional Buys How Can Tomahawk 6 Contribute to Broadcom's AI Growth Story? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
